SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-073021
Filing Date
2019-12-16
Accepted
2019-12-16 16:03:32
Documents
4
Period of Report
2019-12-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm19252461_8k.htm 8-K 20501
2 EXHIBIT 99.1 tm19252461_ex99-1.htm EX-99.1 12764
3 EXHIBIT 99.2 tm19252461_ex99-2.htm EX-99.2 17679
4 GRAPHIC image_001.jpg GRAPHIC 11327
  Complete submission text file 0001104659-19-073021.txt   67958
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 191287068
SIC: 2834 Pharmaceutical Preparations